DrugPatentWatch Database Preview
Janssen R And D Company Profile
What is the competitive landscape for JANSSEN R AND D, and when can generic versions of JANSSEN R AND D drugs launch?
JANSSEN R AND D has two approved drugs.
There are four US patents protecting JANSSEN R AND D drugs.
There are one hundred and thirty-four patent family members on JANSSEN R AND D drugs in thirty-nine countries and twelve supplementary protection certificates in eleven countries.
Summary for Janssen R And D
| International Patents: | 134 |
| US Patents: | 4 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Janssen R And D
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-002 | Dec 22, 2010 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-003 | Mar 26, 2012 | RX | Yes | No | 8,003,789*PED | ➤ Sign Up | Y | ➤ Sign Up | |||
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-002 | Dec 22, 2010 | RX | Yes | Yes | 8,003,789*PED | ➤ Sign Up | Y | ➤ Sign Up | |||
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-003 | Mar 26, 2012 | RX | Yes | No | 7,887,845*PED | ➤ Sign Up | Y | ➤ Sign Up | |||
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-003 | Mar 26, 2012 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Janssen R And D Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Norway | 318801 | ➤ Sign Up |
| Hungary | 0104177 | ➤ Sign Up |
| Croatia | P20010310 | ➤ Sign Up |
| Australia | 1046200 | ➤ Sign Up |
| Portugal | 1225874 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Janssen R And D Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 528 | Luxembourg | ➤ Sign Up | 91528, EXPIRES: 20230828 |
| 0373 | Netherlands | ➤ Sign Up | 300373, 20191101, EXPIRES: 20230827 |
| C033/2008 | Ireland | ➤ Sign Up | SPC033/2008: 20090914, EXPIRES: 20230827 |
| C0004 | France | ➤ Sign Up | PRODUCT NAME: ETRAVIRINE AINSI QUE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: EU/1/08/468/001 DU 20080828; REGISTRATION NO/DATE AT EEC: EU/1/08/468/001 DU 20080828 |
| 2009 00004 | Denmark | ➤ Sign Up | |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
